Mehmet Serdar Yildirim

Mehmet Serdar Yildirim

Auto-generated profile, based on publicly available information

Mehmet Serdar Yildirim

Department of Internal Medicine, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
MYMehmet Serdar Yıldırım
Mehmet Serdar Yıldırım
YGYunus Güzel
Yunus Güzel
CCCanan Can
Canan Can
IKİhsan KAPLAN
İhsan KAPLAN
VŞVeysi Şenses
Veysi Şenses
HKHalil Kömek
Halil Kömek
The prevalence of metastatic colorectal cancer (mCRC) is increasing and is linked to poor overall survival (OS). Previous studies have aimed to determine the predictive value of scores and laboratory tests for OS in mCRC patients, but their findings have been inconclusive. In this research, we focused on determining the prognostic significance of the fibrosis-4 (FIB-4) index, the aspartate aminotransferase (AST) to platelet (PLT) ratio index (APRI), the albumin–bilirubin (ALBI) score, and the gamma-glutamyl transpeptidase to PLT ratio (GPR) with respect to OS in treatment-naïve mCRC patients. This retrospective study included treatment-naïve mCRC patients. The FIB-4 index, ALBI score, APRI, and GPR were calculated for each participant, and their mortality dates were recorded. The clinical importance of these scores for survival outcomes was evaluated via the Cox regression model, Kaplan–Meier method, and log-rank test. The study enrolled 123 untreated mCRC patients. Univariate Cox regression analysis demonstrated that sex and AST/PLT and ALT/PLT counts were not associated with OS (p > 0.05 for all). However, a higher FIB-4 index (p = 0.025), ALBI score (p < 0.001), GPR (p < 0.001), and AST/ALT ratio (p < 0.001) were all associated with poor OS. Additionally, multivariate Cox regression analysis indicated that age (95% CI: 1.009–1.053, p = 0.006), ALBI score (95% CI: 1.234–2.983, p = 0.004), GPR (95% CI: 1.442–2.701, p < 0.001), and AST/ALT (95% CI: 1.193–2.911, p = 0.006) were independent prognostic factors for OS. The affordable and easily accessible ALBI score, GPR, and AST/ ALT have prognostic value in untreated patients with mCRC.

11 December 2025 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
İSİhsan Solmaz
İhsan Solmaz
HKHalil Kömek
Halil Kömek
FKFethullah Kayan
Fethullah Kayan
CCCanan Can
Canan Can
IKİhsan KAPLAN
İhsan KAPLAN
EAEşref Araç
Eşref Araç

27 March 2023 in Anatolian Current Medical Journal
Verified
Journal Article
Open access
PDF file
IKİhsan KAPLAN
İhsan KAPLAN
YGYunus Güzel
Yunus Güzel
CCCanan Can
Canan Can
CGCihan Gundogan
Cihan Gundogan
MYMehmet Serdar Yildirim
Mehmet Serdar Yildirim
HKHalil Kömek
Halil Kömek
Aim: In this study, we aimed to investigate the effects of proton pump inhibitors (PPIs) administered shortly before intravenous (iv) F-18 fluorodeoxyglucose (FDG) injection on the physiological FDG uptake in the gastrointestinal tract (GIS) of patients undergoing F-18 FDG positron emission tomography/computed tomography (PET/CT) for oncological purposes. Material and Method: We retrospectively evaluated 350 patients who underwent 18F-FDG PET/CT in our clinic between November 2020 and June 2021. Among these, 178 patients were given iv PPIs before the scan and the remaining 172 patients with similar characteristics were not. FDG uptake in the gastrointestinal tract was analyzed visually and quantitatively. Results: The mean age of the patients was 51.7±15 years. There was no significant difference between the two groups in terms of age and gender. Quantitative evaluation revealed that the FDG uptakes in the stomach, duodenum, ileum, and transverse colon and their ratio to hepatic uptake were significantly lower in the group receiving iv PPIs (p

1 January 2023 in Intercontinental Journal of Internal Medicine
Verified
Journal Article
Open access
UKUmut Karabulut
Umut Karabulut
İSİhsan Solmaz
İhsan Solmaz
SÖSüleyman Özçaylak
Süleyman Özçaylak
HEHalit Eraslan
Halit Eraslan
SPSipan Polat
Sipan Polat
MYMehmet Serdar Yıldırım
Mehmet Serdar Yıldırım
Endocrinologic examinations encounter hyperprolactinemia, which is the release of prolactin hormone in excess of normal amounts, more frequently than any other pathological condition. In this case , we present a case of it is explained that a 42-year-old male patient can be diagnosed with prolactinoma by deepening the anamnesis without specifics symptoms. It is aimed to raise awareness on this issue.

30 June 2022 in TURKISH JOURNAL of CLINICS and LABORATORY
Verified
Journal Article
Open access
PDF file
ŞKŞafak Kaya
Şafak Kaya
MYMehmet Serdar Yildirim
Mehmet Serdar Yildirim
SKSeyhmus Kavak
Seyhmus Kavak
MAMehmet Fuat Alakuş
Mehmet Fuat Alakuş
MGMehmet Diyaddin Güleken
Mehmet Diyaddin Güleken
SKSehmuz Kaya
Sehmuz Kaya
Amaç: COVID 19 salgını günümüzde önemli bir morbidite ve mortalite ile devam etmektedir. Sağlık personeli bu salgında en yüksek riske sahiptir. O nedenle aşılamada ilk başta sağlık çalışanlarından başlanmıştır. Biz bu çalışmada aşı sonrası sağlık personellerinin antikor düzeyini irdelemeyi amaçladık. Gereç ve Yöntemler: Bu bir retrospektif çalışmadır. CoronaVac aşısı yapılan ve aşı sonrası antikor seviyesi bakılan toplam 102 sağlık personeli çalışmaya dahil edilmiştir. Bulgular: Vakaların 77 (%75.5)’si erkek, 25 (%24.5)’i kadın, yaş ortalaması 43,25±9,97 idi. Vakaların 8 (%7.8)’i daha önce COVID-19 geçirmişti. Ortalama antikor seviyesi 1768,02 ± 3586,09 idi. Kadınlarda antikor ortalaması 2127,9±4716,1; erkeklerde 1651,2±3163,8 idi. Fakat cinsiyet ile antikor seviyesi arasında fark yoktu (p=0.564). Yaş ve antikor seviyesi arasında da fark saptanmadı (p=0.596). Sonuç: Sağlık çalışanları arasında aşı sonrası antikor gelişimi iyiydi. COVID-19 geçiren sağlık çalışanlarının tümünde antikor yanıtı vardı. Populasyonda antikor yanıtı gelişmeyen sadece 3 kişi idi.

5 June 2025 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
BBBilgin Bahadır Başgöz
Bilgin Bahadır Başgöz
MÇMustafa Çetin
Mustafa Çetin
GKGökhan Köker
Gökhan Köker
İSİhsan Solmaz
İhsan Solmaz
MYMehmet Serdar Yıldırım
Mehmet Serdar Yıldırım
MNMehmet İlkin Naharcı
Mehmet İlkin Naharcı
Trust is at the core of the patient-physician relationship. The Trust in Physician Scale (TPS) was specifically developed to measure such interpersonal trust and has high validity and reliability. In this study, we aimed to assess the reliability and validity of the Turkish TPS (TPS-TR) among community-dwelling older adults. This prospective study enrolled community-dwelling older adults aged 65 years and older. The TPS-TR and other scales of generalized anxiety disorder-7 scale (GAD-7), and multidimensional trust in health care systems scale (MTHCSS) subscale-1 “trust in health care providers” were administered to all participants. We assessed the internal consistency, item-total correlations, temporal stability, factor analysis, convergent and discriminant validity of TPS-TR. The study included 230 individuals. TPS-TR demonstrated high internal consistency (Cronbach’s α = 0.866) and remarkable test-retest reliability (ICC = 0.903). The lowest item-to-total correlation was observed for item 5, with a value of 0.375, which was also considered acceptable (> 0.20). TPS-TR was strongly correlated with the MTHCSS subscale-1 (p < 0.001), suggesting high convergent validity, and showed no correlation with GAD-7 (p = 0.087) indicating adequate discriminative validity. The results of our study showed that the TPS-TR has high reliability and validity in measuring the interpersonal trust of community-dwelling older adults in their physicians. Not applicable.